ClinicalTrials.Veeva

Menu

High-density Activation Mapping of the Slow Pathwayto Guide Catheter Ablation in Patients With Typical Atrioventricular Nodal Reentrant Tachycardia

P

Parc de Salut Mar

Status

Completed

Conditions

Atrioventricular Nodal Re Entrant Tachycardia
Supraventricular Tachycardia

Treatments

Device: Description of Slow pathway signals to facilitate ablation

Study type

Interventional

Funder types

Other

Identifiers

NCT05531903
CEIm 2022/10521

Details and patient eligibility

About

Atrioventricular nodal reentrant tachycardia (AVNRT) is the most common supraventricular tachycardia inducible during an electrophysiological study. Although ablative therapy proved to be the treatment of choice, little is known about the components of the tachycardia circuit. The aim of this study is to detect the presence and patterns of specific electrograms representing slow pathway (SP) potentials and to explore Koch's triangle pattern activation during sinus rhythm and/or atrial extraestimulus with a high-density mapping catheter in an attempt to clarify a fast and safety catheter ablation strategy. We hypothesized that, in patients with dual atrioventricular nodal physiology, during sinus rhythm (SR), high-density mapping (HDM) catheters could identify the SP signals, making possible to delineate small areas of slow conduction associated to abnormal electrograms on Koch's triangle. On a second step, radiofrequency (RF) applications safety guided by the HDM obtained with this method, should interrupt the circuit far from the His region. Finally, SP signals should disappear after the RF procedure when performing a new 3D HDM. A control group of patients without AVN dual physiology should show absence of fragmented/slow conduction zones.

Enrollment

119 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients > 18 yo with AVNRT observed after electrophysiological study

Exclusion criteria

  • Patients < 18 yo

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

119 participants in 1 patient group

Patients with atrioventricular node reentrant tachycardia
Experimental group
Description:
Patient with documented AVNRT and fragmented/slow conduction zones observed in a 3D high density mapping
Treatment:
Device: Description of Slow pathway signals to facilitate ablation

Trial contacts and locations

1

Loading...

Central trial contact

Ermengol VG Valles Gras, MD PhD; Jesús Ignacio JL Jimenez López, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems